Navigation Links
ADVENTRX Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26
Date:10/15/2009

SAN DIEGO, Oct. 15 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company's Principal Executive Officer, Brian M. Culley, will present at the BIOCOM Investor Conference on Monday, October 26, 2009, at 10:00 a.m. Pacific time, at the Hyatt Regency in La Jolla, California.

Interested parties can access a live audio webcast and slide presentation on the ADVENTRX Pharmaceuticals Web site at www.adventrx.com. An archived presentation will be available on the Web site for 30 days.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a specialty pharmaceutical company whose product candidates are designed to improve the safety of existing cancer treatments. More information can be found on the Company's web site at www.adventrx.com.

SOURCE ADVENTRX Pharmaceuticals, Inc.


'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. ADVENTRX Pharmaceuticals Announces Closing of Financing
2. ADVENTRX Announces Results From ANX-514 Bioequivalence Study
3. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
4. ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
5. ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results
6. ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
7. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
8. ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
9. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
10. ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer
11. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...Internet Week of Action ,, SILVER SPRING, Md.,...and Drug Administration today completed a coordina...ternational Internet Week of Action (IIWA), intend...cts. ,, (Logo: http://www.newscom.com/cgi-bin/...he FDA,s Office of Criminal Investigations (OCI), ...
(Date:11/19/2009)... Breast-Specific Gamma Imaging/Mol...ed and endorsed by two highly esteemed organizatio...y of Breast Imaging (SBI) and the American College...pporting the further application of this breakthro...breast cancer. ,, "These endorsements reinforce...
(Date:11/19/2009)... Internet Week of Action ,, SILVER SPRING, Md....and Drug Administration today completed a coordina...ternational Internet Week of Action (IIWA), intend...cts. ,, (Logo: http://www.newscom.com/cgi-bin... the FDA,s Office of Criminal Investigations (OCI)...
Breaking Medicine Technology:UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 3FDA Issues 22 Warning Letters to Web Site Operators 2New Technology Helps Athletes Prevent Dehydration and Heat Related Illness 55720 1New Technology Helps Athletes Prevent Dehydration and Heat Related Illness 55720 2Team Garmin Slipstream Announces POM Wonderful Sponsorship 55715 1Team Garmin Slipstream Announces POM Wonderful Sponsorship 55715 2Team Garmin Slipstream Announces POM Wonderful Sponsorship 55715 3Photos 3A Breaking The No White After Labor Day Fashion Myth 55710 1Photos 3A Breaking The No White After Labor Day Fashion Myth 55710 2
...Incorporated,(Nasdaq: SPEX ) reported that patien...s potential type 2 diabetes drug, Naturlose(R), ha...ovide more than 300 patients spread,across 35 site...ent efforts,are underway in India, we believe that...s reported during the May 2008 Annual Shareholders...
...v. 6 Portola,Pharmaceuticals, a biopharmaceutical...significant advances in cardiovascular and inflamm...ata relevant to betrixaban, the,company,s novel or...P,receptor antagonist, will be presented at the Am... 2008. The conference will be held at the Ernest,N...
Other Medicine Technology:Patient Recruitment Begins in India for Phase 3 Diabetes Trial 2Portola Announces Data Presentations Relevant to Its Lead Phase II Antithrombotic Compounds at American Heart Association Scientific Sessions 2008 2
(Date:11/20/2009).... 20 /PRNewswire-FirstCall/ - NUCRYST Pharmaceutic...f Shareholders will be held on Monday, December 21...approval of two special resolutions. The first spe...le of all or substantially all of the assets of NU...the asset purchase agreement dated November 10, 20...
(Date:11/20/2009)... 20 Following a recall by Unilever...rom sale Shedd,s Country Crock ® Side Dishes ...rock ® Side Dishes DELUXE Four Cheese Pasta d...ollowing code dates and UPCs are affected: ,, ...eddar Broccoli Rice 21 oz, UPC 027400218316, Best ...
(Date:11/20/2009)...RNewswire-USNewswire/ -- The American Dental Assoc...ministration (FDA) to establish appropriate classi...ting concern about the safety of whitening product...of professional consultation or examination by a d...of chemically based tooth whitening or bleaching a...
(Date:11/20/2009)..., Nov. 20 Samuel Gladdi...ne what it means to be "happy" during the holidays...ialty in family counseling and chair of the Depart...ding says research shows that it is the pressure t...pression during the holidays. ,, That,s why he,...
(Date:11/20/2009)...e November 20 in the Journal of the National Canc...hopes that often appear in news coverage of cancer...h the media and journals to help alleviate the pro... Woloshin, M.D., M.S., of Center for Medicine and ...licy and Clinical Practice in New Hampshire, and B...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2
...8 Mylan Inc. (Nasdaq: MYL ) today announced the...esloratadine Tablets, 5 mg, the generic version of.... This litigation has been pending in the U.S. Dis...he U.S. on July 1, 2012, or earlier in certain cir...
...ns and Logicalis Initiate Collaborative Sales Agre...tivity Implementations and Access to Federal Healt...pressus, a leader in interoperability of disparate...tions. These collaborative sales development and i...
... Aethlon Medical, Inc. (OTC Bulletin Board: AEMD)...n interview and corporate presentation made by Cha... Small-Cap Investor Conference and Health Tech Inv... , , Aethlon Medical,s full company presentation ...
... "Western,s new Octi-Flo2™ is an ... care for eight patients at once," stated Jul...rises. , Westlake, OH (PR...lp Medical Response Teams to care for multiple pat...
... In New York City- Athlete and Lymelife,s wr...isease. Lyme Disease advocate and athlete, Perry ...se. Wanting to celebrate the movie and to decide f...s personal real life inspiration for the movie. ,...
... Although the median price of the average Ne...e January, 2009 (1 April, 09 Bloomberg Report); th... NZ dollar decline of between 16 and 28 percent ag... Island. , Christchurch, ...
Other Medicine News:Health News:Mylan Announces Clarinex(R) Settlement Agreement 2Health News:Compressus Launches Partnerships With Two Avnet HealthPath(TM) Partners to Accelerate Access to Interoperability Solutions 2Health News:Compressus Launches Partnerships With Two Avnet HealthPath(TM) Partners to Accelerate Access to Interoperability Solutions 3Health News:Compressus Launches Partnerships With Two Avnet HealthPath(TM) Partners to Accelerate Access to Interoperability Solutions 4Health News:Aethlon Medical Announces CEO Interview and Corporate Presentation Available Online 2Health News:Aethlon Medical Announces CEO Interview and Corporate Presentation Available Online 3Health News:Octi-Flo2™ - 8 Patient Portable Oxygen Delivery System 2Health News:Recovered Lyme Disease and US Track and Field Athlete Attends Movie Premiere of LymeLife 2Health News:Recovered Lyme Disease and US Track and Field Athlete Attends Movie Premiere of LymeLife 3Health News:Recovered Lyme Disease and US Track and Field Athlete Attends Movie Premiere of LymeLife 4Health News:New Zealand Beach Front Property Offers Global Currency Rate Bargains 2
...th the Tupos LV/A+, the single-lead principle has ...for the first time. The complete system, which con... A+ lead, minimizes the scope of surgery and the r...m the atrium and the ventricle via a single lead. ...
...e Medtronic InSync II Marquis incorporates the lat...chronization benefits include separately programma... unique patient needs. Also included are new atria... heart failure patients who also experience atrial...
MRI-compatible brain biopsy needles.
RapidLoc Meniscal Repair System
Medicine Products: